These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 9922988)
1. Cognitive implications for H3 and 5-HT3 receptor modulation of cortical cholinergic function: a parallel story. Passani MB; Blandina P Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):725-33. PubMed ID: 9922988 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266 [TBL] [Abstract][Full Text] [Related]
3. Agonist and antagonist effects of histamine H3 receptor ligands on 5-HT3 receptor-mediated ion currents in NG108-15 cells. Allen MC Eur J Pharmacol; 1998 Nov; 361(2-3):261-8. PubMed ID: 9865516 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. Fox GB; Esbenshade TA; Pan JB; Radek RJ; Krueger KM; Yao BB; Browman KE; Buckley MJ; Ballard ME; Komater VA; Miner H; Zhang M; Faghih R; Rueter LE; Bitner RS; Drescher KU; Wetter J; Marsh K; Lemaire M; Porsolt RD; Bennani YL; Sullivan JP; Cowart MD; Decker MW; Hancock AA J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077 [TBL] [Abstract][Full Text] [Related]
5. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure. Stark H; Hüls A; Ligneau X; Purand K; Pertz H; Arrang JM; Schwartz JC; Schunack W Arch Pharm (Weinheim); 1998 Jun; 331(6):211-8. PubMed ID: 9713254 [TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists. Tyers MB Therapie; 1991; 46(6):431-5. PubMed ID: 1840227 [TBL] [Abstract][Full Text] [Related]
18. Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H3 histamine receptors. Prast H; Tran MH; Fischer H; Kraus M; Lamberti C; Grass K; Philippu A Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):558-64. PubMed ID: 10598795 [TBL] [Abstract][Full Text] [Related]
19. [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex. Alves-Rodrigues A; Leurs R; Wu TS; Prell GD; Foged C; Timmerman H Br J Pharmacol; 1996 Aug; 118(8):2045-52. PubMed ID: 8864541 [TBL] [Abstract][Full Text] [Related]
20. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Esbenshade TA; Browman KE; Bitner RS; Strakhova M; Cowart MD; Brioni JD Br J Pharmacol; 2008 Jul; 154(6):1166-81. PubMed ID: 18469850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]